Cite

HARVARD Citation

    Allen, E. et al. (n.d.). TYRA-200: Potent Against FGFR2 Fusions, Molecular Brake Mutations and Gatekeeper Resistance. European journal of cancer. pp. S16-. [Online]. 
  
Back to record